-
AB4344
Anti-LYAR Antibody (Ly1 Antibody reactive clone) (C15-1316-158)
Price: $828.00List Price: $920.00LYAR, also known as Ly1 antibody reactive clone, has been found to regulate the intracellular strength that is stimulated by both T and B cell antigen receptors. It is essential for immune tolerance and certain changes to its function could -
HPA039179-100UL
Anti-LYG2 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen lysozyme G-like 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the -
HPA001231-100UL
Anti-LYN antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen LYN proto-oncogene, Src family tyrosine kinase Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA042511-100UL
Anti-LYPD5 antibody produced in rabbit (C15-1457-244)
Price: $928.29List Price: $1,031.43Immunogen LY6/PLAUR domain containing 5 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA054670-100UL
Anti-LYPD5 antibody produced in rabbit (C15-1461-759)
Price: $977.14List Price: $1,085.71Immunogen LY6/PLAUR domain containing 5 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in -
HPA050941-100UL
Anti-LYPLA1 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen lysophospholipase I recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
HPA045806-100UL
Anti-LYPLAL1 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen lysophospholipase-like 1 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported -
HPA063932-100UL
Anti-LYRM2 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen LYR motif containing 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA050053-100UL
Anti-LYRM7 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen Lyrm7 homolog (mouse) recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
ABE496
Anti-Lysine-specific demethylase 5C Antibody (C15-1317-185)
Price: $672.00List Price: $746.67Lysine-specific demethylase 5C is also called Histone demethylase JARID1C, Jumonji/ARID domain-containing protein 1C, Protein SmcX and Protein Xe169. Lysine-specific demethylase 5C is a histone demethylase that specifically targets trimethylated -
HPA028055-100UL
Anti-LYSMD1 antibody produced in rabbit (C15-1451-694)
Price: $879.43List Price: $977.14Immunogen LysM, putative peptidoglycan-binding, domain containing 1 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) -
HPA064537-100UL
Anti-LYSMD1 antibody produced in rabbit (C15-1464-647)
Price: $928.29List Price: $1,031.43Immunogen LysM, putative peptidoglycan-binding, domain containing 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most